López Andreu F R, Munar-Qués M, Parrilla P, Escribano Soriano J B, Costa P P, Costa P M, Almeida M R, Pons J A, Robles R, Sánchez-Bueno F
Servicio de Medicina Interna, Hospital General Universitario, Murcia.
Med Clin (Barc). 1993 Nov 6;101(15):581-3.
The first liver transplantation carried out in Spain for the treatment of type I familial amyloidotic polyneuropathy (FAP I) is presented. The reason for the operation was based on the liver being responsible for the synthesis of abnormal transtirretin (TTR) constituting the peculiar amyloid of the disease. Following transplantation a rapid and noticeable decrease in abnormal TTR was observed and the evolution of the clinical picture after 18 months of surgery is favorable with progressive improvement of the neurologic symptoms and normal function of the graft. These encouraging results coincide with those of the Swedish group of Umea, the pioneer of this procedure.
本文介绍了西班牙首例为治疗I型家族性淀粉样多神经病(FAP I)而进行的肝移植手术。手术的依据是肝脏负责合成构成该疾病特殊淀粉样蛋白的异常转甲状腺素蛋白(TTR)。移植后观察到异常TTR迅速且显著下降,术后18个月的临床症状进展良好,神经症状逐渐改善,移植肝功能正常。这些令人鼓舞的结果与该手术的先驱——瑞典于默奥小组的结果一致。